JPRN-jRCT2080220849未知2 期
A Phase II, MultiCenter, Randomized, Double-blind, Placebo-controlled Study of TAS-102 in Patients with Chemotherapy-Refractory Advanced Colorectal Cancer.
试验速览
- 阶段
- 2 期
- 入组人数
- 162
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1)Patients with colorecotal cancer, who had received prior therapy, at least two regimens, containing fluoropyrimidine, oxaliplatin, and irinotecan
- •2)Patients must be able to take orally
排除标准
- •1)Patient who has serious concomitant disease
- •2)Patient who had received TAS-102
研究者
相似试验
未知
2 期
A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple SclerosisMultiple SclerosisJPRN-jRCT2080222132ovartis Pharma K.K.380
招募中
2 期
A Study to see effect and safety of PNB-001 capsules in Inflammatory bowel diseaseCTRI/2022/10/046658PNB Vesper Life Science Pvt Ltd
招募中
2 期
AMG0103 in Subjects with Chronic Discogenic Lumber Back PaiChronic Discogenic Lumber Back PainJPRN-jRCT2031230145Sakai Daisuke92
已完成
2 期
A Study of JNJ-73763989 + Nucleos(t)ide Analog in Participants Co-infected with Hepatitis B and Hepatitis D VirusJPRN-jRCT2071200049akama Takahiro190
进行中（未招募）
1 期
Phase 2 study of the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of KPL-404 in subjects with moderate to severe Rheumatoid ArthritisRheumatoid arthritis (RA)MedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2022-000169-42-DEKiniksa Pharmaceuticals, Ltd.131